BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today published a case study highlighting the positive impact of University of Rochester Medical Center’s (URMC) transformative, system-wide deployment of Butterfly’s point-of-care ultrasound (POCUS) devices and enterprise ultrasound platform, Compass™.

马萨诸塞州伯灵顿市和纽约州——（商业新闻短讯）——蝴蝶网络公司（“蝴蝶”，“公司”）（纽约证券交易所：BFLY）是一家数字健康公司，通过便携式、基于半导体的超声波技术和直观软件的力量来改变护理，今天发表了一份案例研究，强调了罗切斯特大学医学中心（URMC）变革性、全系统部署蝴蝶即时超声波（POCUS）设备和企业超声波平台Compass™的积极影响。

The results are backed by an academic paper published yesterday, September 16, 2024, in the Journal of Clinical Imaging Science..

这一结果得到了昨天（2024年9月16日）发表在《临床影像科学杂志》上的一篇学术论文的支持。。

In early 2021, URMC partnered with Butterfly to launch an enterprise-wide ultrasound program designed to improve access to imaging, enhance clinical workflows, and drive value for both patients and providers. To date, URMC has deployed 862 Butterfly devices across 64 academic departments and clinical programs, integrated with Butterfly’s Compass™ workflow software.

2021年初，URMC与Butterfly合作推出了一项企业范围的超声波计划，旨在改善成像的获取，增强临床工作流程，并为患者和提供者带来价值。迄今为止，URMC已在64个学术部门和临床项目中部署了862台蝶形设备，并与蝶形Compass™工作流软件集成。

URMC plans to scale the program to 2,500 devices by 2026. This innovative implementation has resulted in a 116% increase in ultrasound charge capture across the health system..

URMC计划到2026年将该计划扩展到2500台设备。这种创新的实施使整个卫生系统的超声波电荷捕获增加了116%。。

Since 2022, nearly 50,000 scanning sessions have been completed, generating over 175,000 images and 15,524 finalized reports. This growth has fueled a 74% increase in scanning sessions in 2023, a 147% rise in studies uploaded from Butterfly devices and a 1,782% jump in images uploaded from non-Butterfly devices.

自2022年以来，已经完成了近50000次扫描，产生了175000多张图像和15524份最终报告。这一增长推动了2023年扫描会话的增加74%，从蝴蝶设备上传的研究增加了147%，从非蝴蝶设备上传的图像增加了1782%。

These achievements have contributed to earlier diagnoses, such as detecting cholecystitis, abscesses and bladder masses, significantly improving patient outcomes while reducing emergency visits..

这些成就有助于早期诊断，例如检测胆囊炎，脓肿和膀胱肿块，显着改善患者预后，同时减少急诊就诊。。

“Our phased deployment of Butterfly devices and Compass software has yielded impressive clinical and administrative results at URMC to date. URMC is proud to be at the forefront of the wide-scale deployment of innovative point-of-care ultrasound technology, and we believe it shows promise as the right care model for the medical community at large,” commented Michael F.

“迄今为止，我们分阶段部署的蝴蝶装置和指南针软件在URMC取得了令人印象深刻的临床和管理成果。URMC很自豪能够在创新的即时超声波技术的广泛部署中走在前列，我们相信它有望成为整个医疗界正确的护理模式，”迈克尔·F评论道。

Rotondo, MD, Chief Executive Officer of the University of Rochester Medical Faculty Group, Senior Vice President of URMC..

Rotondo医学博士，罗切斯特大学医学院集团首席执行官，URMC高级副总裁。。

“I’m inspired by Dr. Rotondo’s visionary leadership in driving the system-wide deployment of point-of-care ultrasound across URMC. Patients are receiving care earlier, doctors are empowered to make a greater impact, and care is becoming more efficient – proving a compelling return on investment,” said Joseph DeVivo, president, CEO, and board chairman of Butterfly Network.

蝴蝶网络（Butterfly Network）总裁、首席执行官兼董事会主席约瑟夫·德维沃（Joseph DeVivo）表示：“罗通多博士在推动整个URMC系统范围内部署即时超声波方面的富有远见的领导，让我深受鼓舞。患者更早地接受了护理，医生有权发挥更大的影响，护理效率也越来越高，这证明了投资的巨大回报。”。

“Health system leaders are recognizing the power of POCUS as a comprehensive solution. Thousands of studies confirm early diagnoses across venues annually, yet many go unrecorded and unreimbursed, resulting in millions of dollars in unbilled ultrasound scans. Individual providers are already onboard; tens of thousands have purchased their own Butterfly devices knowing they improve patient care.

“卫生系统领导人正在认识到POCUS作为一种综合解决方案的强大作用。每年有数千项研究证实了各个场馆的早期诊断，但许多研究没有记录，也没有支付费用，导致数百万美元的未付费超声扫描。个别供应商已经加入；数万人购买了自己的蝴蝶设备，知道它们可以改善患者护理。

Now it’s time for health system C-suites to work with those doctors to build an enterprise-wide POCUS program. This means committing to education, deploying Butterfly’s Compass Software, and integrating Butterfly iQ3 across their institution to deliver state-of-the-art early diagnosis and unlock these strong clinical and financial results.”.

现在是时候让health system C-suites与这些医生合作，建立一个企业范围的POCUS计划了。这意味着致力于教育，部署Butterfly的Compass软件，并将Butterfly iQ3整合到他们的机构中，以提供最先进的早期诊断并解锁这些强大的临床和财务成果。”。

To read the full case study visit: ​​https://butterflynetwork.com/case-studies-urmc. For more information on Butterfly Network, visit www.butterflynetwork.com.

阅读完整的案例研究访问：https://butterflynetwork.com/case-studies-urmc.有关蝴蝶网的更多信息，请访问www.butterflynetwork.com。

For more information on the University of Rochester Medical Center, visit https://www.urmc.rochester.edu.

有关罗切斯特大学医学中心的更多信息，请访问https://www.urmc.rochester.edu.

About Butterfly Network

关于Butterfly Network

Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network is a digital health company with a mission to democratize medical imaging by making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound.

蝴蝶网络（Butterfly Network）由乔纳森·罗斯伯格（Jonathan Rothberg）博士于2011年成立，是一家数字健康公司，其使命是通过提供价格合理、易于使用、全球可访问且智能连接的高质量超声波，使医疗成像民主化，包括为全球47亿无法使用超声波的人提供超声波。

Butterfly created the world's first handheld single-probe, whole-body ultrasound system using semiconductor technology, Butterfly iQ. The company has continued to innovate, leveraging the benefits of Moore’s Law, to launch its second-generation Butterfly iQ+ in 2020, and third generation iQ3 in 2024 – each with increased processing power and performance enhancements.

Butterfly利用半导体技术创建了世界上第一个手持式单探头全身超声系统Butterfly iQ。该公司利用摩尔定律的优势，不断创新，于2020年推出第二代Butterfly iQ+，2024年推出第三代iQ3，每一代都具有更高的处理能力和性能增强。

The disruptive technology has been recognized by TIME’s Best Inventions, Fast Company’s World Changing Ideas, CNBC Disruptor 50, and MedTech Breakthrough Awards, among other accolades. With its proprietary Ultrasound-on-Chip™ technology, intelligent software, and educational offerings, Butterfly is paving the way to mass adoption of ultrasound for earlier detection and remote management of health conditions around the world.

这项颠覆性技术已获得《时代》最佳发明奖、Fast公司改变世界的理念奖、CNBC Disruptor 50奖和MedTech突破奖等荣誉。凭借其专有的超声波芯片技术、智能软件和教育产品，Butterfly正在为超声波在全球范围内的早期检测和远程管理铺平道路。

Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to learn more about available countries, visit: www.butterflynetwork.com/choose-your-country..

蝶形装置可在非洲、亚洲、澳大利亚、欧洲、中东、北美和南美部分地区的训练有素的医疗保健从业人员那里买到；要了解有关可用国家的更多信息，请访问：www.butterflynetwork.com/choose your country。。